Results 131 to 140 of about 4,113 (206)

Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in heart failure: the DECISION trial. [PDF]

Eur Heart J
van der Meer P, van Veldhuisen DJ, Voordes GHD, Tijssen J, Alings M, Bouvy ML, Swart HP, Houtgraaf HJ, Dorman HGR, Rienstra M, Damman K, Mosterd A.   +11 more
europepmc   +1 more source

Exploring the Anticancer Potential of Plant, Marine, and Synthetic Glycosides: A Comprehensive Review. [PDF]

Biomolecules
Jabeen T, Akram S, Ahmad M, Al-Hussain SA, Zaki MEA.   +4 more
europepmc   +1 more source

Proteome mining of Yersinia Enterocolitica for drug targets and computational inhibitor identification with ADMET, anti-inflammation potential and formulation characteristics. [PDF]

BioData Min
Basharat Z, Alghamdi YS, Mashraqi MM, Ogaly HA, Al-Zahrani FAM, Wei CR, Ahmed I, Kim S.   +7 more
europepmc   +1 more source

Bioactivity of Cyperus amuricus extracts against hepatocellular carcinoma and molecular docking analysis targeting the PI3K/AKT/mTOR pathway. [PDF]

PLoS One
Nguyen TL, Tu TK, Phan TV, Nguyen CM, Nguyen KD, Pham MQ, Pham Thi HH.   +6 more
europepmc   +1 more source

Heart failure in the elderly: epidemiology, mechanisms, and management. [PDF]

Eur Heart J
de Boer RA, Abdellatif M, Bauersachs J, Roger VL.   +3 more
europepmc   +1 more source

DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trials. [PDF]

Eur J Heart Fail
Bavendiek U, Thomas NH, Berliner D, Liu X, Schwab J, Rieth A, Maier LS, Schallhorn S, Angelini E, Soltani S, Rathje F, Sandu MA, Geller W, Gaspar T, Hambrecht R, Zdravkovic M, Philipp S, Kosevic D, Nickenig G, Scheiber D, Winkler S, Becher PM, Lurz P, Hülsmann M, von Karpowitz M, Schröder C, Neuhaus B, Seltmann A, von der Leyen H, Veltmann C, Störk S, Böhm M, Koch A, Großhennig A, Bauersachs J, DIGIT‐HF Study Group.   +35 more
europepmc   +1 more source

Repurposing of NKA inhibitors ('cardiac glycosides'): a critical analysis. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Evans K, Seifert R.
europepmc   +1 more source

Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial. [PDF]

Nat Med
van Veldhuisen DJ, Rienstra M, Mosterd A, Alings M, Voors AA, Damman K, van Asselt ADI, Bouvy ML, Schaap J, van der Wall EE, Crijns HJGM, Touw DJ, Hoogslag PAM, van de Swaluw JEC, Schuurman RJ, van der Sluis A, Bondarenko O, Römer TJ, Oosterhof T, Bartels GL, Koudstaal S, Dijkmans PA, Linssen GCM, Aksoy I, Dorman HGR, Schut A, Hemels MEW, Tieleman RG, Lok DJA, Westendorp ICD, Vijver MAT, Voordes GHD, de Vos AH, Maas-Soer EL, Postmus D, Lunter G, Tijssen JGP, van der Meer P.   +37 more
europepmc   +1 more source

Repurposing acetyldigitoxin as a potential EZH2 inhibitor for non-small cell lung cancer: a computational and experimental approach. [PDF]

J Comput Aided Mol Des
Ji X, Wang X, Xiu T, Gao M, Lu D.
europepmc   +1 more source